Abbott Laboratories

ABT05 Dec 2024
Healthcare
$116.37
0.00 (-0.32%)
Lowest Today
$115.29
Highest Today
$116.53
Today’s Open
$116.37
Prev. Close
$116.29
52 Week High
$121
52 Week Low
$99.24
To Invest in Abbott Laboratories

Abbott Laboratories

Healthcare
ABT05 Dec 2024
0.00 (-0.32%)
1M
3M
6M
1Y
5Y
Low
$115.29
Day’s Range
High
$116.53
115.29
52 Week Low
$99.24
52-Week Range
52 Week High
$121
99.24
1 Day
-
1 Week
-2.23%
1 month return
-1.15%
3 month return
+1.66%
6 month return
+12.45%
1 Year return
+10.56%
3 Years return
-12.16%
5 Years return
+36.51%
10 Years return
-
Institutional Holdings
Vanguard Group Inc
9.68
BlackRock Inc
7.56
State Street Corp
4.42
Capital Research & Mgmt Co - Division 3
3.79
Vanguard Total Stock Mkt Idx Inv
3.17
Capital Research Global Investors
3.07
Vanguard Institutional 500 Index Trust
2.66

Market Status

Fundamentals
Market Cap
202602.27 mln
PB Ratio
5.18
PE Ratio
35.5
Enterprise Value
213192.33 mln
Total Assets
73214 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Organisation
Abbott Laboratories
Employees
114000
Industry
Medical Devices
CEO
Mr. Robert B. Ford
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities